Posted inOpinion

Baker’s Orwellian drug pricing policy

THE BAKER ADMINISTRATION recently released its budget proposal for one of their most high-profile issues: drug prices in the Medicaid program. To the surprise of many in the biopharmaceutical industry, there are some promising initiatives in the proposal from an administration that is thought to be hostile to the industry on drug prices. By far the most […]

Posted inOpinion

E-scripts for opioids save lives

GOV. CHARLIE BAKER recently signed into law a bill to mitigate the state-level effects of the ongoing opioid crisis. Like other such legislative efforts at both the federal and state levels, this important legislation requires healthcare providers and pharmacies to switch to electronic prescribing of controlled substances. This most recent legislative success reflects just how […]

Posted inOpinion

Cost barriers rise for patients

THERE SEEMS TO be a new story each day about how patients across the country are being treated unfairly by their health insurance company. Chances are, you or someone you love has been through something like this. These are patients who have done the right thing, worked hard, paid their premiums, and expected that when […]

Posted inOpinion

Taxpayers clean up Big Pharma’s mess

LAST YEAR, the United States saw a 13 percent increase in drug overdose deaths, from an estimated 60,147 lives lost in 2016, to an estimated 67,944 in 2017. For perspective, that is enough to completely fill Gillette Stadium, with an overflow of 2,066 individuals. Here in Massachusetts, we experienced a slight decrease in opioid related […]

Posted inOpinion

Electronic opioid scripts save lives

A HEARING EARLIER this month on Beacon Hill underscored the critical need for Massachusetts-specific solutions to the nation’s opioid crisis. As the Legislature prepares next steps to address this critical issue, it would do well to consider a bill recently proposed by Gov. Charlie Baker that would capitalize on technological advances to help address the […]